Core Laboratories (CLB) Reports In-Line Q1 EPS, Offers FY and Q2 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Morgan Stanley Downgrades Core Laboratories (CLB) to Underweight
April 24, 2014 6:59 AM EDTMorgan Stanley downgraded Core Laboratories (NYSE: CLB) from Overweight to Underweight.
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.
Shares of Core Laboratories closed at $213.69 yesterday.
... More